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Telomere length maintenance is regarded as a
fundamental step in tumorigenesis, as most human brain
tumors, including meningiomas, stabilize the ends of their
chromosomes using telomerase. This investigation
represents an introduction to telomerase expression in
canine and feline meningiomas. Twenty-five archived
cases (14 dogs and 11 cats) were immunohistochemically
tested for human-telomerase reverse transcriptase (h-
TERT), scored, and quantified; furthermore, mitoses
were counted on sections stained with a modified toluidine
blue. The h-TERT antibody immunolabelled the nucleus
and nucleolus of meningeal neoplastic cells, with an
intensity ranging from mild to strong and a speckled
distribution; a significantly higher expression in cats was
noted, while no significant association between h-TERT
immunolabelling and sex or histotype was evident in dogs
or cats. The telomerase enzyme represents a fundamental
parameter of potential malignant transformation, which
may occur independently of the signal to proliferate,
thereby supplying the cells with unlimited growth
capabilities. Telomerase expression could be a prognostic
indicator independent of the kinetic parameters, although
this should be evaluated using a larger dataset with
available clinical information.
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Introduction
Telomerase is a ribonucleoprotein complex that prevents
the erosion of chromosomal extremities (telomeres) in
eukaryotes. These sequences are composed of multiple G-
rich repeats and an abundance of associated proteins.
The telomerase enzyme is formed by an RNA component
and a reverse transcriptase, the catalytic subunit which is
considered to be the primary determinant for its activity [5].
The human-telomerase reverse transcriptase (h-TERT)
immunohistochemistry (IHC) supplies an indirect indication
of the presence of the enzyme.
Maintenance of telomere length is essential for tumorigenesis,
as most human tumors stabilize their chromosome ends
using telomerase [5]. Many types of tumors, including brain
cancers, have been studied by utilizing these procedures.
Meningiomas, which may arise anywhere along the
meninges, are the most common types of primary brain
tumors in domestic animals; they are usually discrete, slow
growing masses with smooth surfaces and broad dural
attachments [3].
Recently, a subset of 27 canine meningiomas was tested
for telomerase immunoreactivity, and TERT expression was
found to be significantly correlated with the MIB1 antibody
labelling index [4].
The aim of this study was to expand the present
knowledge regarding telomerase expression in both canine
and feline meningiomas.
Materials and Methods
Twenty-five cases of meningiomas (14 canine and 11
feline) were selected and classified according to the World
Health Organization (WHO) scheme [3].
h-TERT immunohistochemistry
Replicate sections were tested for the presence of the
enzymatic catalytic subunit of telomerase, h-TERT. Endogenous
peroxidase activity was blocked by immersion in 0.3%
hydrogen peroxide in methanol for 30 min; slides were
immersed in citrate buffer (pH 6.0), heated for two 5 min
periods in a microwave oven at 750 W. The primary
antibody, an anti-human TERT (Clone 44F12, diluted 1 : 50
in PBS; Novocastra, UK), was applied to the slides
*Corresponding author
Tel: +39-51-2097970; Fax: +39-51-2097968
E-mail: luciana.mandrioli@unibo.it112 Luciana Mandrioli et al.
overnight at 4
oC, followed by a streptavidin-biotin-
peroxidase complex (LSAB Kit; Dako, Netherlands) and
diaminobenzidine (0.04% for 7 min) as chromogen.
Sections were then counterstained with Papanicolaou
hematoxylin, rinsed in tap water, dehydrated, and mounted.
An isotype-matched IgG negative control was run on each
section. Canine normal testis was used as a positive tissue
control.
The h-TERT index was assessed by an image analyzer
(Lucia 32G/Mutech; Nikon, Japan) in ten fields (×20 lens)
and expressed as the percentage of positive cells.
Furthermore, h-TERT labelled cells were subjectively
estimated using semiquantitative grading, in which 0
indicated the absence of positive cells, 1 was 1-10% of
positive cells, 2 was 11-30% of positive cells, 3 was 31-60%
of positive cells, and 4 was more than 61% of positive cells.
Mitosis count
Mitoses were counted in five fields (×40 lens) on replicate
sections stained with a toluidine blue technique, which was
modified to enhance the detectibility of mitotic figures [1].
Mitotic activity was then graded as low (L): 0-5 mitoses, or
high (H): >6 mitoses.
Statistical analysis
Parametric one-way analysis of variance (ANOVA) was
performed to compare h-TERT values with histologic type,
gender and species. Simple logistic regression analysis was
used to evaluate the association between the two tested
methods (subjective and automated).
A value of p < 0.05 was considered to be significant.
Results
In canine meningiomas, the histotypes most often observed
were meningothelial (7/14) and anaplastic (4/14), followed
by fibroblastic (1/14), transitional (1/14), and psammomatous
(1/14), with a strong predominance of females (9/14).
Among cats, the transitional variety was mostly represented
(6/11), followed by psammomatous (2/11) and anaplastic (2/
11); a predominance of males was noted (7/11) (Table 1).
Concerning IHC, h-TERT protein was localized in the
nucleus, notably the nucleolus, and was also occasionally
found in the cytoplasm of neoplastic meningothelial cells (2
cases) (Fig. 1A-C) (Table 1). In three specimens out of 25,
no signal was detected; in the remaining samples, the
staining intensity ranged from mild to strong, being very
variable from case to case. The distribution of immuno-
reactive cells was speckled throughout the slide; even the
percentage was very variable, with the proportion of positive
cells ranging from 0 to 90%. According to the adopted
semiquantitative grading system of h-TERT immuno-
positivity, five cases were classified in group 0, seven in
group 1, two in group 2, seven in group 3, and four in group
4 (Table 1).
The comparison of the two tested counting systems
indicated a direct positive correlation between the two
methods (r = 0.881; p = 0.0000).
h-TERT expression was higher in meningioma samples
from cats than in those from dogs (automated count in dogs:
mean 23.3%, range: 0.71-73.91%; automated count in cats:
mean 42.3%, range 15.93-68.87%; p = 0.06). No other
association was evident between h-TERT immunolabelling
and sex or histotype for dogs or cats.
Modified toluidine blue staining (Fig. 2) was useful to
appreciate a very low mitotic activity in the vast majority of
meningiomas (L group: 21 out of 25); only four cases
evidenced a high number of mitotic figures (H group: 4 out
of 25), including three dogs (2 anaplastic, 1 meningothelial)
and one cat (anaplastic meningioma) (Table 1).
No correlation between the number of h-TERT immuno-
reactive cells (telomerase expression) and their proliferative
activity, assessed by mitotic count on toluidine blue-stained
sections, was evident.
Discussion
In our series, canine meningiomas were more frequently
found to be of the pure meningothelial type than of other
types, although the WHO classification schemes report the
transitional variety to be the most commonly observed in
dogs [3]; nevertheless, the transitional variant shows features
of both meningothelial and fibroblastic meningiomas.
Furthermore, meningiomas occurred more frequently in
female dogs and male cats; this finding mirrors the results of
other reports [11], and has been putatively related to a
dissimilar expression of estrogen, progesterone, and androgen
receptors in canine and feline meningiomas [7].
Telomerase expression, which is assessed by h-TERT
IHC, was displayed in expected locations, mainly nucleolar
and nuclear locations, as previously reported, and also was
rarely found in cytoplasmic locations [9]. Strong nucleolar
staining may be explained as the presence of the telomerase
holoenzyme, which is assembled within the nucleolus. The
nuclear labelling may represent the active telomerase
complex at the ends of the chromosome. Conversely, the
cytoplasmic staining may be interpreted as the shuttling of
telomerase holoenzyme from the nucleus, out to the
cytoplasm, and then back into the nucleus during the
assembly process [4]. This machinery is well-known
because the relevance of telomerase in the process of
tumoral transformation has been investigated thoroughly. In
fact, its activation is considered to be a fundamental step in
the “immortalization” of neoplastic cells, and has been
suggested to play a key role in the progression of several
tumors including human intracranial meningiomas [6]. The
data obtained in the present study also seem to support this
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The correlation observed between the subjective semi-
quantitative grading and the automated count was highly
significant, considering the two systems to be interchangeable
in the evaluation of h-TERT IHC. With both measurement
systems, there was no appreciable relationship between h-
TERT expression and the meningioma histotype, or with
other variables such as gender and age. The h-TERT
expression tended to be higher in samples from feline
meningiomas than in canine meningiomas, and this may
suggest a different role of the telomerase pathway between
the two species, and may indicate a different prognostic
significance.
In most human and animal tumors, the proliferative
activity of neoplastic cells is directly related to the biological
behavior. For this reason, the proliferative activity is
considered to be a relevant prognostic factor that can be
assessed by the counting of mitoses, or by the immuno-
histochemical evaluation of proteins expressed throughout
the cell cycle (i.e. Ki67 antigen recognized by MIB1
antibody) [10]. In this respect, arachnoid “cap” cells, from
which meningiomas arise, have a slow rate of cell division
[2], and therefore a high mitotic activity cannot be expected
in their tumoral transformations. Noticeably, MIB1
immunostaining was ineffective in our series (data not
shown). This behavior can be explained with prolonged
storage of samples (in formalin or in paraffin blocks), which
is responsible for subcellular modifications (i.e. cross-
linking between proteins and/or nucleic acids that provides a
strong steric hindrance creating an intricate physical barrier
to antibodies employed in IHC) [8]. Therefore, the
proliferative activity of tumor cells has been evaluated by
counting mitoses in sections stained with a modified
toluidine blue technique, which enhances the detectibility of
mitotic figures. Most cases prompted a very low proliferative
activity (L group: 21 out of 25); only four cases displayed
relatively high mitoses counts, which suggested a more
aggressive phenotype, and three of these were grouped in
the anaplastic histotype, that, among other meningioma
Table 1. Synopsis of signalment, histological classification, telomerase expression, and mitotic activity in meningiomas from dogs and
cats*
No Species Age
(yrs) Sex WHO histotype h-TERT
staining pattern
h-TERT
labelling index
h-TERT
grading
Mitotic
activity
1 Dog 17 F Meningothelial 0 0 0 L
2 Dog 4 M Meningothelial N 0.83 0 H
3 Dog 9 F Meningothelial N, Nu 38.44 3 L
4 Dog 10 F Meningothelial 0 0 0 L
5 Dog 8 F Meningothelial N 41.90 1 L
6 Dog 10 F Meningothelial N 22.46 2 L
7 Dog 7 F Meningothelial N 26.49 2 L
8 Dog 10 F Fibroblastic N, Nu, C 6.16 1 L
9 Dog 6 F Transitional N, Nu 42.12 1 L
10 Dog 11 M Psammomatous N, Nu, C 73.91 4 L
11 Dog 3 F Anaplastic N 2.01 1 H
12 Dog 5 M Anaplastic N 0.71 0 H
13 Dog 11 M Anaplastic N, Nu 69.74 3 L
14 Dog 12 M Anaplastic N 1.65 1 L
15 Cat 9 M Transitional N 49.90 3 L
16 Cat 5 M Transitional N, Nu 27.82 3 L
17 Cat 9 F Transitional N, Nu 56.06 4 L
18 Cat 12 M Transitional N, Nu 68.87 3 L
19 Cat 16 M Transitional N, Nu 15.93 1 L
20 Cat 15 M Transitional N, Nu 19.64 1 L
21 Cat 12 F Fibroblastic N, Nu 64.85 4 L
22 Cat 8 M Psammomatous 0 0 0 L
23 Cat 12 F Psammomatous N, Nu 48.36 4 L
24 Cat 12 F Anaplastic N, Nu 54.09 3 H
25 Cat 12 M Anaplastic N, Nu 60.00 3 L
*h-telomerase reverse transcriptase (h-TERT) staining pattern; distribution within nucleus (N), nucleolus (Nu) and cytoplasm (C ). h-TERT labelling
index; number of cells assessed by image analysis, and expressed as percentage of positive cells. h-TERT grading; subjective ev aluation, 0 (no cells are
labelled), 1 (1-10% of cells are labelled), 2 (11-30%), 3 (31-60%), 4 (more than 61%). Mitotic activity; number of mitoses coun ted in 5 fields (× 40), L
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variants, behaves in an aggressive fashion and carries a
much poorer prognosis than do benign meningiomas
(malignant meningioma).
Several studies have attempted to assess the proliferative
potential and the existence of an association between
meningioma recurrence and MIB1 labelling index in patient
groups with low and high risk of recurrence, attributing a
prognostic significance to the mitotic index and to the Ki-67
labelling index [12]; however, the actual prognostic relevance
of these parameters remains controversial, heterogeneous,
and of uncertain value [10]. In this respect, it has been
postulated that h-TERT expression might be a relevant
marker of progression towards recurrence and malignancy
of meningiomas [6].
In the present study, no significant association between h-
TERT expression and the histological type of meningioma
or the mitoses count was evident, although a recent paper
reports an association between h-TERT and MIB1 staining in
canine brain tumors (meningioma and oligodendroglioma)
[4]. A possible explanation for this is that telomerase
activation, a fundamental parameter of potential malignant
transformation, may occur independently of the signal to
proliferate, thereby supplying the cells with unlimited
growth capabilities [6].
These preliminary findings suggest that telomerase
expression could play a role as a prognostic indicator that
acts independently of kinetic parameters, although this
should be evaluated using a larger dataset with available
clinical information.
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